Third Harmonic Bio (Series B)

Funding Details
Awarder
Inbox
Date Award
February 17, 2022
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$105,000,000

Company Info
Company Description
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.
Market
Allergy and Inflammation Treatment
Location
Cambridge, MA, USA
Coinvestors
Ajax Health, Boxer Capital, BVF Partners, Commodore Capital, Deep Track Capital, General Atlantic, RA Capital Management, RTW Investments

Links